Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell.
Diabetologia
; 66(11): 1971-1982, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37488322
ABSTRACT
Type 1 diabetes results from the poorly understood process of islet autoimmunity, which ultimately leads to the loss of functional pancreatic beta cells. Mounting evidence supports the notion that the activation and evolution of islet autoimmunity in genetically susceptible people is contingent upon early life exposures affecting the islets, especially beta cells. Here, we review some of the recent advances and studies that highlight the roles of these changes as well as antigen presentation and stress response pathways in beta cells in the onset and propagation of the autoimmune process in type 1 diabetes. Future progress in this area holds promise for advancing islet- and beta cell-directed therapies that could be implemented in the early stages of the disease and could be combined with immunotherapies.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Islets of Langerhans
/
Diabetes Mellitus, Type 1
/
Insulin-Secreting Cells
Limits:
Humans
Language:
En
Journal:
Diabetologia
Year:
2023
Type:
Article
Affiliation country:
Canada